Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins

用修饰蛋白​​在体外和细胞内研究生物调节

基本信息

  • 批准号:
    10371143
  • 负责人:
  • 金额:
    $ 51.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract We have developed a technique for randomizing 23S ribosomal RNA structure, and for selecting modified ribosomes which incorporate into proteins specific types of modified amino acids not ordinarily incorporated by wild-type ribosomes. Species incorporated both in vitro and in vivo have included nucleobase amino acids, dipeptides/dipeptidomimetics, beta-amino acids, phosphorylated amino acids and glycosylated amino acids. The selected ribosomes enable study of two key biochemical regulatory processes, i.e. protein glycosylation and phosphorylation. We will also modify regulatory proteins that interact with nucleic acids, enabling predictable modulation or altered specificity of interactions. We will exemplify new strategies using proteins containing unusual non-proteinogenic amino acids, whose incorporation requires our selected ribosomes. The creation of proteins phosphorylated stoichiometrically at single or multiple positions affords new opportunities. These include the ability to verify natural phosphorylations, and to study their effects. It permits the introduction of (metabolically stable) phosphate groups in vivo, and has enabled new strategies for identifying residues whose phosphorylation modifies function. We showed that phosphorylation of IB- Tyr42 not only relaxes NF-B inhibition, but facilitates the rate of binding to a gene whose expression NF-B regulates. We plan to study two other known phosphorylation sites in IB-, and three in NF-BWhile some sites of serine phosphorylation in NF-B are known, this is not true for Tyr and Thr. Using a new strategy, we have identified four sites of Tyr phosphorylation, and plan to study new Thr and Ser phosphorylation sites. Most mammalian proteins are glycosylated, but understanding/altering carbohydrate functions is challenging. Using a selected ribosome in a cell free system, we prepared murine interferon- (IFN-) containing GlcNAc- Asn at position 29, which can confer antiviral activity. This intermediate acceptor substrate should enable carbohydrate cluster transfer, producing IFN- fully glycosylated at position 29, and expected to have antiviral activity. We have recently introduced the same glycosylated amino acid, and its peracetylated analogue, into a model protein in very good yield in cellulo. This strategy can potentially produce the same intermediate as that prepared in vitro, but in much larger quantities. We wish to prepare fully glycosylated proteins with natural carbohydrate clusters, to simplify these clusters, and to focus on the inclusion of residues such as sialic acid. Cell regulation often involves protein–DNA interactions; low nanomolar affinities and impressive selectivity are typical. Many X-ray crystal structures could guide design changes, but attempts to alter these regulatory processes by changing affinity or specificity have failed. Using Rob proteins having nucleobase amino acids, we modified binding to their micF DNA partners, realizing stronger binding, and enhanced phenotypic cellular responses. We propose to study the Rob–micF DNA interactions further to refine our design techniques. The principles developed will be used to address protein–DNA recognition in a Zn finger system.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sidney M. Hecht其他文献

Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants
  • DOI:
    10.1016/j.bmc.2017.01.030
  • 发表时间:
    2017-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Arnaud Chevalier;Omar M. Khdour;Margaret Schmierer;Indrajit Bandyopadhyay;Sidney M. Hecht
  • 通讯作者:
    Sidney M. Hecht
Metabolic activation of 1-methyl-3-amino-5H-pyrido[4,3-b]indole and several structurally related mutagens.
1-甲基-3-氨基-5H-吡啶并[4,3-b]吲哚和几种结构相关诱变剂的代谢激活。
  • DOI:
  • 发表时间:
    1981
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    J. Pezzuto;J. Pezzuto;J. Pezzuto;Patrick D. Moore;Patrick D. Moore;Sidney M. Hecht;Sidney M. Hecht
  • 通讯作者:
    Sidney M. Hecht
Chemical synthesis of lipophilic methylene blue analogues which increase mitochondrial biogenesis and frataxin levels
  • DOI:
    10.1016/j.dib.2018.08.156
  • 发表时间:
    2018-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Indrajit Bandyopadhyay;Sandipan Roy Chowdhury;Nishant P. Visavadiya;Sidney M. Hecht;Omar M. Khdour
  • 通讯作者:
    Omar M. Khdour
DNA strand scission by naturally occurring 5-alkylresorcinols
天然存在的 5-烷基间苯二酚导致 DNA 链断裂
  • DOI:
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. T. Scannell;J. R. Barr;V. S. Murty;K. Reddy;Sidney M. Hecht
  • 通讯作者:
    Sidney M. Hecht
Activation of span class="small-caps"d/span‑Asparagine and span class="small-caps"d/span‑Glutamine Derivatives Using the Mitsunobu Reaction
使用 Mitsunobu 反应激活 d-天冬酰胺和 d-谷氨酰胺衍生物
  • DOI:
    10.1021/acs.orglett.3c00232
  • 发表时间:
    2023-09-08
  • 期刊:
  • 影响因子:
    5.000
  • 作者:
    Xuan Fu;Yuqin Shang;Shengxi Chen;Larisa M. Dedkova;Sidney M. Hecht
  • 通讯作者:
    Sidney M. Hecht

Sidney M. Hecht的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sidney M. Hecht', 18)}}的其他基金

Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins
用修饰蛋白​​在体外和细胞内研究生物调节
  • 批准号:
    10613406
  • 财政年份:
    2021
  • 资助金额:
    $ 51.81万
  • 项目类别:
Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins
用修饰蛋白​​在体外和细胞内研究生物调节
  • 批准号:
    10164536
  • 财政年份:
    2021
  • 资助金额:
    $ 51.81万
  • 项目类别:
Ribosomally Synthesized Proteins Incorporating Modified Dipeptides
掺入修饰二肽的核糖体合成蛋白质
  • 批准号:
    9378075
  • 财政年份:
    2017
  • 资助金额:
    $ 51.81万
  • 项目类别:
Selection of Modified Ribosomes Using Novel Puromycins
使用新型嘌呤霉素选择修饰核糖体
  • 批准号:
    8918685
  • 财政年份:
    2013
  • 资助金额:
    $ 51.81万
  • 项目类别:
Selection of Modified Ribosomes Using Novel Puromycins
使用新型嘌呤霉素选择修饰核糖体
  • 批准号:
    8733730
  • 财政年份:
    2013
  • 资助金额:
    $ 51.81万
  • 项目类别:
Selection of Modified Ribosomes Using Novel Puromycins
使用新型嘌呤霉素选择修饰核糖体
  • 批准号:
    10061609
  • 财政年份:
    2013
  • 资助金额:
    $ 51.81万
  • 项目类别:
Selection of Modified Ribosomes Using Novel Puromycins
使用新型嘌呤霉素选择修饰核糖体
  • 批准号:
    8576387
  • 财政年份:
    2013
  • 资助金额:
    $ 51.81万
  • 项目类别:
Molecular Recognition by Bleomycin
博来霉素的分子识别
  • 批准号:
    7781632
  • 财政年份:
    2010
  • 资助金额:
    $ 51.81万
  • 项目类别:
Dynamic Properties that Enhance Enzyme Function
增强酶功能的动态特性
  • 批准号:
    8052862
  • 财政年份:
    2010
  • 资助金额:
    $ 51.81万
  • 项目类别:
Molecular Recognition by Bleomycin
博来霉素的分子识别
  • 批准号:
    8013856
  • 财政年份:
    2010
  • 资助金额:
    $ 51.81万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 51.81万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了